Simó M, Persiva O, Sánchez L, Montoro J B, Sansano I, Vázquez A, Ascanio F, Alemán C
Departments of Nuclear Imaging, Grupo de Patología Pleural, Universitat Autònoma de Barcelona, University Hospital Vall d'Hebron, Barcelona, Spain.
Departments of Radiology, Grupo de Patología Pleural, Universitat Autònoma de Barcelona, University Hospital Vall d'Hebron, Barcelona, Spain.
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2025 Jan-Feb;44(1):500059. doi: 10.1016/j.remnie.2024.500059. Epub 2024 Sep 10.
Histological analysis of the pleura obtained by video-assisted thoracoscopic surgery (VATS) is the best diagnostic technique in the study of neoplastic pleural effusions. This study evaluates the relationship between Positron Emission Tomography (PET)/Computed Tomography (CT) and VATS findings, the result of the first pleural biopsy, and the final diagnosis of malignancy or non-malignancy.
Prospective study of consecutive patients with pleural effusions undergoing PET/CT and VATS from October 2013 to December 2023. The following variables were recorded: PET/CT score (nodular pleural thickening, pleural nodules with standardized uptake value (SUV) > 7.5, lung mass or extra pleural malignancy, mammary lymph node with SUV > 4.5 and cardiomegaly); VATS data (drained volume, visceral and parietal pleural thickening, nodules or masses, septa, plaques, fluid appearance, trapped lung, and suspected diagnosis of the procedure), as well as the histological study of the first pleural biopsy (benign or malignant) and the final diagnosis of benign or malignant pleural effusion. A logistic regression study of the variables was performed.
95.8% of the patients with PET/CT and pleuroscopy not suggestive of malignancy had non-malignant histological findings, while 93.2% of the patients with PET/CT and pleuroscopy suggestive of malignancy had malignant histological findings. PET/CT, pleuroscopy, and the result of the first pleural biopsy showed a significant association with the final diagnosis of pleural effusion.
There is a strong association between PET/CT findings, VATS and pleural histology.
通过电视辅助胸腔镜手术(VATS)获取胸膜组织进行组织学分析是研究肿瘤性胸腔积液的最佳诊断技术。本研究评估正电子发射断层扫描(PET)/计算机断层扫描(CT)与VATS检查结果、首次胸膜活检结果以及恶性或非恶性最终诊断之间的关系。
对2013年10月至2023年12月期间连续接受PET/CT和VATS检查的胸腔积液患者进行前瞻性研究。记录以下变量:PET/CT评分(结节性胸膜增厚、标准化摄取值(SUV)>7.5的胸膜结节、肺肿块或胸膜外恶性肿瘤、SUV>4.5的乳腺淋巴结和心脏肥大);VATS数据(引流液量、脏层和壁层胸膜增厚、结节或肿块、间隔、斑块、液体外观、肺陷闭以及手术的疑似诊断),以及首次胸膜活检的组织学研究(良性或恶性)和胸腔积液的最终良性或恶性诊断。对变量进行逻辑回归研究。
PET/CT和胸腔镜检查不提示恶性肿瘤的患者中,95.8%的患者组织学检查结果为非恶性,而PET/CT和胸腔镜检查提示恶性肿瘤的患者中,93.2%的患者组织学检查结果为恶性。PET/CT、胸腔镜检查和首次胸膜活检结果与胸腔积液的最终诊断显著相关。
PET/CT检查结果、VATS与胸膜组织学之间存在密切关联。